rs398122403
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong
The NM_203446.3(SYNJ1):c.656G>A(p.Arg219Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000116 in 1,461,844 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R219W) has been classified as Uncertain significance.
Frequency
Consequence
NM_203446.3 missense
Scores
Clinical Significance
Conservation
Publications
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- developmental and epileptic encephalopathy, 53Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- early-onset Parkinson disease 20Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atypical juvenile parkinsonismInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- young-onset Parkinson diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.0000119 AC: 3AN: 251466 AF XY: 0.0000147 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461844Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727226 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Early-onset Parkinson disease 20 Pathogenic:2
- -
This variant was found in two German patients with epilepsy early in the disease course, followed by progressive generalized dopa-responsive dystonia associated with severe action tremor of the tongue, head, and extremities in their early teen years, and cognitive deterioration. We identified compound heterozygous mutations (NP_982271.2:p.Trp171*/NP_982271.2:p.Arg258Gln) in the SYNJ1 gene, affecting the N-terminal suppressor of actin1 (SAC1)-like domain of the SYNJ1 protein. -
Early-onset Parkinson disease 20;C4479313:Developmental and epileptic encephalopathy, 53 Pathogenic:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 258 of the SYNJ1 protein (p.Arg258Gln). This variant is present in population databases (rs398122403, gnomAD 0.003%). This missense change has been observed in individuals with Parkinson disease (PMID: 23804563, 23804577, 24816432). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 88844). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SYNJ1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SYNJ1 function (PMID: 23804563). For these reasons, this variant has been classified as Pathogenic. -
SYNJ1-related disorder Pathogenic:1
The SYNJ1 c.773G>A variant is predicted to result in the amino acid substitution p.Arg258Gln. This variant was reported in the homozygous and compound heterozygous states in multiple individuals with early onset Parkinsonism (Krebs et al. 2013. PubMed ID: 23804563; Quadri et al. 2013. PubMed ID: 23804577; Olgiati et al. 2014. PubMed ID: 24816432; Rauschendorf et al. 2016. PubMed ID: 27869329). Functional studies of this variant have provided evidence that this variant impacts protein function (Cao et al. 2017. PubMed ID: 28231468; Fasano et al. 2018. PubMed ID: 29515184). This variant is reported in 0.0033% of alleles in individuals of South Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/21-34067416-C-T). This variant is interpreted as pathogenic. -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect with this variant resulting in reduced phosphatase activity and defects in endocytosis at the presynaptic nerve terminals (PMID: 28231468, 23804563); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28231468, 23804563, 29515184, 35810474, 23804577, 27869329, 33841314, 24816432) -
Young-onset Parkinson disease Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at